1. Home
  2. RPC vs IRMD Comparison

RPC vs IRMD Comparison

Compare RPC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ridgepost Capital Inc. Class A Common Stock

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$8.06

Market Cap

960.2M

Sector

Finance

ML Signal

N/A

IRMD

iRadimed Corporation

HOLD

Current Price

$81.95

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPC
IRMD
Founded
1992
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
1.1B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
RPC
IRMD
Price
$8.06
$81.95
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$11.00
$116.00
AVG Volume (30 Days)
514.9K
78.8K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
1.96%
0.95%
EPS Growth
6.25
16.67
EPS
0.14
0.86
Revenue
$297,346,000.00
$83,814,000.00
Revenue This Year
$16.82
$12.38
Revenue Next Year
$15.80
$11.31
P/E Ratio
$58.00
$97.16
Revenue Growth
0.30
14.43
52 Week Low
$6.79
$67.84
52 Week High
$9.51
$107.90

Technical Indicators

Market Signals
Indicator
RPC
IRMD
Relative Strength Index (RSI) 34.92 28.37
Support Level $7.34 $76.95
Resistance Level $8.02 $88.93
Average True Range (ATR) 0.28 2.13
MACD -0.09 -0.24
Stochastic Oscillator 3.54 5.03

Price Performance

Historical Comparison
RPC
IRMD

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Share on Social Networks: